Comparison Between Uterine Artery Doppler and Placental Vascular Indices in Prediction of Preeclampsia

Overview

• Preeclampsia is a multisystem disorder that can cause considerable maternal and fetal morbidity and mortality. Late preeclampsia (with delivery >34 weeks) is more frequent and less serious than early preeclampsia (with delivery <34 weeks). Poor early placentation has been especially associated with early disease. Early identification of women at risk of preeclampsia is currently a crucial aim of antenatal care since they may benefit from prophylactic treatment and increased surveillance.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 1, 2021

Detailed Description

– The introduction of three-dimensional (3D) ultrasound techniques, with the option of calculating placental volume and measuring vascular indices, has created an excellent opportunity to study early changes in the uteroplacental circulation space, which includes the maternal spiral arteries and the intervillous space. This technology may allow a more direct evaluation of the abnormal placentation process thought to herald the development of preeclampsia. – The aim of this study was to assess the usefulness of placental volume and 3D vascular indices as reliable predictors of early preeclampsia in comparison to uterine artery Doppler

Interventions

  • Device: ultrasound machine
    • Ultrasound machine with a vocal software

Arms, Groups and Cohorts

  • control group
    • Pregnant women: Age between 18-35 years Parity: primigravidas and multiparas. Have no history of preeclampsia or eclampsia. Have no history of chronic hypertension. Not diabetic. Not have antiphospholipid syndrome. Not have autoimmune disease such as SLE
  • High risk group
    • Pregnant women with: History of preeclampsia -Eclapmsia Chronic hypertension Diabetic Antiphospholipid syndrome. Autoimmune syndrome such as SLE.

Clinical Trial Outcome Measures

Primary Measures

  • placental vascular indices in prediction of preeclampsia
    • Time Frame: one year
    • placental vascular indices in prediction of preeclampsia compared to uterine artery doppler in prediction of preeclampsia

Participating in This Clinical Trial

Inclusion Criteria

  • A. Control group: Pregnant women: 1. Age between 18-35 years 2. Parity: primigravidas and multiparas. 3. Have no history of preeclampsia or eclampsia. 4. Have no history of chronic hypertension. 5. Not diabetic. 6. Not have antiphospholipid syndrome. 7. Not have autoimmune disease such as SLE. B. High risk group: Pregnant women with: 1. History of preeclampsia -Eclapmsia 2. Chronic hypertension 3. Diabetic 4. Antiphospholipid syndrome. 5. Autoimmune syndrome such as SLE. Exclusion Criteria:

  • • Smoking – Dichorionic placentae – Fetal anomaly – Uterine fibroid at the site of placental implantation – Subchorionic hematoma

Gender Eligibility: Female

examination of pregnant women

Minimum Age: 18 Years

Maximum Age: 35 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • National Research Centre, Egypt
  • Provider of Information About this Clinical Study
    • Principal Investigator: Sherif Elsirgany, Researcher ,Family Planning and Reproductive Health Department – National Research Centre, Egypt
  • Overall Contact(s)
    • SHERIF MOHAMMED ELSIRGANY, DOCTOR, +201223607191, SHERIFELSIRGANY@YAHOO.COM

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.